Business Description
Lupin Ltd
SIC : 2833
ISIN : INE326A01037
Share Class Description:
NSE:LUPIN: Ordinary SharesTotal Employee Number:
28,137Compare
Compare
Traded in other countries / regions
500257.India Index Membership
NIFTY 500 IPO Date
2001-09-10Description
Lupin Ltd is a transnational pharmaceutical company engaged in producing, developing, and marketing branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The Company has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti-Inflammatory Drug therapy segments and the Anti-TB and Cephalosporins segments. It operates through two segments: Pharmaceuticals, which consists of producing, developing, and marketing pharmaceutical products, and Others, which consists of diagnostic services, Digital healthcare services, and the neuro-rehabilitation business. The Company operates in India, the USA, and other countries, with maximum revenue from the USA.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.2 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 0.71 | |||||
Interest Coverage | 16.67 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 6.12 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19 | |||||
3-Year EBITDA Growth Rate | 67.5 | |||||
3-Year EPS without NRI Growth Rate | 134.1 | |||||
3-Year FCF Growth Rate | 136.6 | |||||
3-Year Book Growth Rate | 21.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.87 | |||||
9-Day RSI | 38.68 | |||||
14-Day RSI | 35.38 | |||||
3-1 Month Momentum % | -4.09 | |||||
6-1 Month Momentum % | -3.06 | |||||
12-1 Month Momentum % | 9.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.9 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.63 | |||||
Days Inventory | 278.78 | |||||
Days Sales Outstanding | 75.75 | |||||
Days Payable | 167.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.86 | |||||
Dividend Payout Ratio | 0.1 | |||||
3-Year Dividend Growth Rate | 44.2 | |||||
Forward Dividend Yield % | 0.86 | |||||
5-Year Yield-on-Cost % | 1.54 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -1.2 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.13 | |||||
Operating Margin % | 25.52 | |||||
Net Margin % | 18.72 | |||||
EBITDA Margin % | 31.71 | |||||
FCF Margin % | 17.14 | |||||
OCF Margin % | 23.99 | |||||
ROE % | 27.98 | |||||
ROA % | 16.41 | |||||
ROIC % | 24.79 | |||||
3-Year ROIIC % | 72.39 | |||||
ROC (Joel Greenblatt) % | 62.35 | |||||
ROCE % | 34.65 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.26 | |||||
Forward PE Ratio | 21.72 | |||||
PE Ratio without NRI | 17.63 | |||||
Shiller PE Ratio | 58.83 | |||||
Price-to-Owner-Earnings | 15.03 | |||||
PEG Ratio | 0.35 | |||||
PS Ratio | 3.23 | |||||
PB Ratio | 4.25 | |||||
Price-to-Tangible-Book | 5.75 | |||||
Price-to-Free-Cash-Flow | 18.07 | |||||
Price-to-Operating-Cash-Flow | 13.02 | |||||
EV-to-EBIT | 12.21 | |||||
EV-to-Forward-EBIT | 21.32 | |||||
EV-to-EBITDA | 10.34 | |||||
EV-to-Forward-EBITDA | 15.59 | |||||
EV-to-Revenue | 3.28 | |||||
EV-to-Forward-Revenue | 3.02 | |||||
EV-to-FCF | 17.91 | |||||
Price-to-GF-Value | 0.8 | |||||
Price-to-Projected-FCF | 2.3 | |||||
Price-to-Median-PS-Value | 1.15 | |||||
Price-to-Graham-Number | 2.17 | |||||
| Price-to-Net-Current-Asset-Value | 11.75 | |||||
Earnings Yield (Greenblatt) % | 8.18 | |||||
FCF Yield % | 5.38 | |||||
Forward Rate of Return (Yacktman) % | 21.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lupin Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 299,665.8 | ||
| EPS (TTM) (₹) | 120.73 | ||
| Beta | 0.4851 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 1.51 | ||
| Volatility % | 15.22 | ||
| 14-Day RSI | 35.38 | ||
| 14-Day ATR (₹) | 39.859835 | ||
| 20-Day SMA (₹) | 2124.175 | ||
| 12-1 Month Momentum % | 9.06 | ||
| 52-Week Range (₹) | 1900 - 2529.5 | ||
| Shares Outstanding (Mil) | 457.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lupin Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lupin Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-02-12 16:00 | In 145 days | ||
| Third quarter earnings results for 2027 | 2027-02-12 | In 144 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-06 16:00 | In 47 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 46 days | ||
| First quarter earnings conference call for 2027 | 2026-08-07 16:30 | 2,385.00 (-0.50%) | ||
| First quarter earnings results for 2027 | 2026-08-07 | 2,385.00 (-0.50%) | ||
| General meeting for 2026 | 2026-08-04 16:00 | 2,393.00 (-1.72%) | ||
| INR 18.000000 Cash Dividend | 2026-07-17 | 2,500.50 (-0.22%) | ||
| Annual report for 2026 | 2026-07-17 | 2,500.50 (-0.22%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-08 16:00 | 2,460.10 (+0.21%) |
Show
Entries
Lupin Ltd Frequently Asked Questions
What is Lupin Ltd(NSE:LUPIN)'s stock price today?
The current price of NSE:LUPIN is ₹2083.00. The 52 week high of NSE:LUPIN is ₹2529.50 and 52 week low is ₹1900.00.
When is next earnings date of Lupin Ltd(NSE:LUPIN)?
The next earnings date of Lupin Ltd(NSE:LUPIN) is 2026-11-06 Est..
Does Lupin Ltd(NSE:LUPIN) pay dividends? If so, how much?
The Dividend Yield %  of Lupin Ltd(NSE:LUPIN) is 0.86% (As of Today), Highest Dividend Payout Ratio of Lupin Ltd(NSE:LUPIN) was 4.6. The lowest was 0.09. And the median was 0.24. The  Forward Dividend Yield % of Lupin Ltd(NSE:LUPIN) is 0.86%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers